Minerva Neurosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Minerva Neurosciences, Inc. (NERV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2024-02-22
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2023-12-31 was $0.00.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2023-09-30 was $0.00.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2023-06-30 was $0.00.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2023-03-31 was $0.00.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $0.00.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $0.00.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $900.00K, a 350.00% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-02-22 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $0.00 10-Q · filed 2023-08-01 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 derived: sum of 4 quarters · filed 2024-02-22 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $0.00 10-Q · filed 2023-08-01 | $0.00 derived: sum of 3 quarters · filed 2023-08-01 | $0.00 derived: sum of 4 quarters · filed 2023-08-01 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2023-05-15 | $0.00 derived: sum of 3 quarters · filed 2023-05-15 | $0.00 derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $0.00 derived: sum of 2 quarters · filed 2023-03-08 | $0.00 derived: sum of 3 quarters · filed 2023-03-08 | $0.00 10-K · filed 2023-03-08 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-08-09 | $0.00 10-Q · filed 2021-11-08 | $0.00 derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-08-09 | $0.00 derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2022-05-04 | $0.00 derived: sum of 3 quarters · filed 2022-05-04 | $600.00K derived: sum of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $600.00K derived: sum of 3 quarters · filed 2022-03-01 | $900.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $600.00K derived: sum of 2 quarters · filed 2021-11-08 | $900.00K 10-Q · filed 2021-11-08 | $900.00K derived: sum of 4 quarters · filed 2021-11-08 | |
| 2020-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $900.00K 10-Q · filed 2021-08-02 | $900.00K derived: sum of 3 quarters · filed 2021-08-02 | $900.00K derived: sum of 4 quarters · filed 2021-08-02 | |
| 2020-03-31 | $300.00K 10-Q · filed 2021-05-12 | $300.00K derived: sum of 2 quarters · filed 2021-05-12 | $300.00K derived: sum of 3 quarters · filed 2021-05-12 | $300.00K derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $0.00 derived: sum of 2 quarters · filed 2021-03-08 | $0.00 derived: sum of 3 quarters · filed 2021-03-08 | $200.00K 10-K · filed 2021-03-08 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $0.00 derived: sum of 2 quarters · filed 2020-11-02 | $200.00K 10-Q · filed 2020-11-02 | $500.00K derived: sum of 4 quarters · filed 2020-11-02 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $200.00K 10-Q · filed 2020-08-03 | $500.00K derived: sum of 3 quarters · filed 2020-08-03 | $300.00K derived: sum of 4 quarters · filed 2020-08-03 | |
| 2019-03-31 | $200.00K 10-Q · filed 2020-05-04 | $500.00K derived: sum of 2 quarters · filed 2020-05-04 | $300.00K derived: sum of 3 quarters · filed 2020-05-04 | $1.00M derived: sum of 4 quarters · filed 2020-05-04 | |
| 2018-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $100.00K derived: sum of 2 quarters · filed 2020-03-09 | $800.00K derived: sum of 3 quarters · filed 2020-03-09 | $800.00K 10-K · filed 2020-03-09 | |
| 2018-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $500.00K derived: sum of 2 quarters · filed 2019-11-04 | $500.00K 10-Q · filed 2019-11-04 | $700.00K 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $700.00K 10-Q · filed 2018-08-02 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-06 | ||||
| 2017-12-31 | $700.00K 10-K · filed 2019-03-12 | ||||
| 2017-03-31 | $200.00K 10-Q · filed 2018-05-03 | $287.00K derived: sum of 2 quarters · filed 2018-05-03 | |||
| 2016-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $100.00K 10-K · filed 2018-03-12 | |||
| 2016-09-30 | $13.00K 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |